Viruses as Sole Causative Agents of Severe Acute Respiratory Tract Infections in Children

PLoS One. 2016 Mar 10;11(3):e0150776. doi: 10.1371/journal.pone.0150776. eCollection 2016.

Abstract

Background: Respiratory syncytial virus (RSV) and influenza A viruses are known to cause severe acute respiratory tract infections (SARIs) in children. For other viruses like human rhinoviruses (HRVs) this is less well established. Viral or bacterial co-infections are often considered essential for severe manifestations of these virus infections.

Objective: The study aims at identifying viruses that may cause SARI in children in the absence of viral and bacterial co-infections, at identifying disease characteristics associated with these single virus infections, and at identifying a possible correlation between viral loads and disease severities.

Study design: Between April 2007 and March 2012, we identified children (<18 year) with or without a medical history, admitted to our paediatric intensive care unit (PICU) with SARI or to the medium care (MC) with an acute respiratory tract infection (ARTI) (controls). Data were extracted from the clinical and laboratory databases of our tertiary care paediatric hospital. Patient specimens were tested for fifteen respiratory viruses with real-time reverse transcriptase PCR assays and we selected patients with a single virus infection only. Typical bacterial co-infections were considered unlikely to have contributed to the PICU or MC admission based on C-reactive protein-levels or bacteriological test results if performed.

Results: We identified 44 patients admitted to PICU with SARI and 40 patients admitted to MC with ARTI. Twelve viruses were associated with SARI, ten of which were also associated with ARTI in the absence of typical bacterial and viral co-infections, with RSV and HRV being the most frequent causes. Viral loads were not different between PICU-SARI patients and MC-ARTI patients.

Conclusion: Both SARI and ARTI may be caused by single viral pathogens in previously healthy children as well as in children with a medical history. No relationship between viral load and disease severity was identified.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Influenza A virus*
  • Influenza, Human / epidemiology*
  • Male
  • Respiratory Syncytial Virus Infections / epidemiology*
  • Respiratory Syncytial Viruses*
  • Respiratory Tract Infections* / epidemiology
  • Respiratory Tract Infections* / virology
  • Severity of Illness Index
  • Tertiary Care Centers
  • Viral Load

Grants and funding

PLAF, MPGK and ADMEO's institutions received funding from EU FP7 project PREPARE (grant number 602525) for studies on the pathogenesis of viruses in children. PLAF and ADMEO received funding from VIRGO project NWO The Netherlands (grant number FES0908). ADMEO receives funding from N-RENNT DFG Germany. AMCVR's institution received funding from the Sophia research Foundation. PLAF and ADMEO participated in the IRIS trial sponsored by Hoffmann-La Roche expenses were paid to their institution. GSK paid a speaker’s fee to the Erasmus MC for PLAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.